These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 24182909)

  • 41. Usefulness of anemia in men as an independent predictor of two-year cardiovascular outcome in patients presenting with acute coronary syndrome.
    Cavusoglu E; Chopra V; Gupta A; Clark LT; Eng C; Marmur JD
    Am J Cardiol; 2006 Sep; 98(5):580-4. PubMed ID: 16923440
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The prognostic value of very low admission LDL-cholesterol levels in ST-segment elevation myocardial infarction compared in statin-pretreated and statin-naive patients undergoing primary percutaneous coronary intervention.
    Oduncu V; Erkol A; Kurt M; Tanboğa IH; Karabay CY; Şengül C; Bulut M; Özveren O; Fotbolcu H; Akgün T; Türkyilmaz E; Kırma C
    Int J Cardiol; 2013 Jul; 167(2):458-63. PubMed ID: 22305817
    [TBL] [Abstract][Full Text] [Related]  

  • 43. What level of hyperglycaemia on admission indicates a poor prognosis in patients with myocardial infarction treated invasively?
    Tomaszuk Kazberuk A; Kożuch M; Małyszko J; Bachórzewska Gajewska H; Dobrzycki S; Kosacka U; Musiał WJ
    Kardiol Pol; 2012; 70(6):564-72. PubMed ID: 22718372
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Ischemic outcomes after coronary intervention of calcified vessels in acute coronary syndromes. Pooled analysis from the HORIZONS-AMI (Harmonizing Outcomes With Revascularization and Stents in Acute Myocardial Infarction) and ACUITY (Acute Catheterization and Urgent Intervention Triage Strategy) TRIALS.
    Généreux P; Madhavan MV; Mintz GS; Maehara A; Palmerini T; Lasalle L; Xu K; McAndrew T; Kirtane A; Lansky AJ; Brener SJ; Mehran R; Stone GW
    J Am Coll Cardiol; 2014 May; 63(18):1845-54. PubMed ID: 24561145
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Five-year outcomes of surgical or percutaneous myocardial revascularization in diabetic patients.
    Contini GA; Nicolini F; Fortuna D; Pacini D; Gabbieri D; Vignali L; Valgimigli M; Manari A; Zussa C; Guastaroba P; De Palma R; Grilli R; Gherli T
    Int J Cardiol; 2013 Sep; 168(2):1028-33. PubMed ID: 23164591
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Hemoglobin levels and coronary artery disease.
    Chonchol M; Nielson C
    Am Heart J; 2008 Mar; 155(3):494-8. PubMed ID: 18294483
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Usefulness of the admission electrocardiogram to predict long-term outcomes after non-ST-elevation acute coronary syndrome (from the FRISC II, ICTUS, and RITA-3 [FIR] Trials).
    Damman P; Holmvang L; Tijssen JG; Lagerqvist B; Clayton TC; Pocock SJ; Windhausen F; Hirsch A; Fox KA; Wallentin L; de Winter RJ
    Am J Cardiol; 2012 Jan; 109(1):6-12. PubMed ID: 21944677
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Acute coronary syndrome complicated by heart failure as predictor of long-term infarction].
    Cháfer N; Palau P; Núñez J; Miñana G; Sanjuán R; Sanchis J
    Rev Clin Esp; 2011 Dec; 211(11):549-59. PubMed ID: 22088668
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Prevalence and prognostic significance of transient, persistent, and new-onset anemia after acute myocardial infarction.
    Hasin T; Sorkin A; Markiewicz W; Hammerman H; Aronson D
    Am J Cardiol; 2009 Aug; 104(4):486-91. PubMed ID: 19660599
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Vorapaxar in acute coronary syndrome patients undergoing coronary artery bypass graft surgery: subgroup analysis from the TRACER trial (Thrombin Receptor Antagonist for Clinical Event Reduction in Acute Coronary Syndrome).
    Whellan DJ; Tricoci P; Chen E; Huang Z; Leibowitz D; Vranckx P; Marhefka GD; Held C; Nicolau JC; Storey RF; Ruzyllo W; Huber K; Sinnaeve P; Weiss AT; Dery JP; Moliterno DJ; Van de Werf F; Aylward PE; White HD; Armstrong PW; Wallentin L; Strony J; Harrington RA; Mahaffey KW
    J Am Coll Cardiol; 2014 Mar; 63(11):1048-57. PubMed ID: 24211500
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Transfusion burden among patients with chronic kidney disease and anemia.
    Lawler EV; Bradbury BD; Fonda JR; Gaziano JM; Gagnon DR
    Clin J Am Soc Nephrol; 2010 Apr; 5(4):667-72. PubMed ID: 20299366
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Anemia management and association of race with mortality and hospitalization in a large not-for-profit dialysis organization.
    Servilla KS; Singh AK; Hunt WC; Harford AM; Miskulin D; Meyer KB; Bedrick EJ; Rohrscheib MR; Tzamaloukas AH; Johnson HK; Zager PG
    Am J Kidney Dis; 2009 Sep; 54(3):498-510. PubMed ID: 19628315
    [TBL] [Abstract][Full Text] [Related]  

  • 53. ST-segment recovery and outcome after primary percutaneous coronary intervention for ST-elevation myocardial infarction: insights from the Assessment of Pexelizumab in Acute Myocardial Infarction (APEX-AMI) trial.
    Buller CE; Fu Y; Mahaffey KW; Todaro TG; Adams P; Westerhout CM; White HD; van 't Hof AW; Van de Werf FJ; Wagner GS; Granger CB; Armstrong PW
    Circulation; 2008 Sep; 118(13):1335-46. PubMed ID: 18779444
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Prognostic implication of anemia on in-hospital outcomes after percutaneous coronary intervention.
    McKechnie RS; Smith D; Montoye C; Kline-Rogers E; O'Donnell MJ; DeFranco AC; Meengs WL; McNamara R; McGinnity JG; Patel K; Share D; Riba A; Khanal S; Moscucci M;
    Circulation; 2004 Jul; 110(3):271-7. PubMed ID: 15226214
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Long-term prognosis of patients with acute myocardial infarction in the era of acute revascularization (from the Heart Institute of Japan Acute Myocardial Infarction [HIJAMI] registry).
    Okura N; Ogawa H; Katoh J; Yamauchi T; Hagiwara N
    Int J Cardiol; 2012 Sep; 159(3):205-10. PubMed ID: 21402419
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Low hemoglobin concentration is associated with poor outcome after peripheral arterial surgery.
    Oshin OA; Torella F
    Vasc Endovascular Surg; 2013 Aug; 47(6):449-53. PubMed ID: 23794093
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Usefulness of plasma matrix metalloproteinase-9 level in predicting future coronary revascularization in patients after acute myocardial infarction.
    Wang KF; Huang PH; Chiang CH; Hsu CY; Leu HB; Chen JW; Lin SJ
    Coron Artery Dis; 2013 Jan; 24(1):23-8. PubMed ID: 23151854
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Predictors of 30-day cardiovascular events in patients with prior percutaneous coronary intervention or coronary artery bypass grafting.
    Esposito EC; Hollander JE; Ryan RJ; Schreiber D; O'Neil B; Jackson R; Christenson R; Gibler WB; Lindsell CJ
    Acad Emerg Med; 2011 Jun; 18(6):613-8. PubMed ID: 21676059
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Outcomes of acute coronary syndrome in a large Canadian cohort: impact of chronic renal insufficiency, cardiac interventions, and anemia.
    Keough-Ryan TM; Kiberd BA; Dipchand CS; Cox JL; Rose CL; Thompson KJ; Clase CM
    Am J Kidney Dis; 2005 Nov; 46(5):845-55. PubMed ID: 16253724
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Effects of chronic renal insufficiency and anemia upon long-term outcomes in patients undergoing percutaneous coronary intervention].
    Liu XM; Kang JP; Lü Q; Hu R; Nie SP; Wu JH; Zhang Y; Jia CQ; Liu XH; Dong JZ; Ma CS; Wu XS
    Zhonghua Yi Xue Za Zhi; 2009 Aug; 89(32):2245-8. PubMed ID: 20095334
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.